Navigation Links
3 Columbia University Medical Center faculty elected to Institute of Medicine

NEW YORK Three distinguished Columbia University Medical Center faculty have been elected to the Institute of Medicine of the National Academy of Sciences this year.

Election to the Institute of Medicine (IOM) is one of the highest honors in the fields of medicine and health, and Columbia now has 49 members in this esteemed organization. The three CUMC faculty Kathryn Calame, Timothy Pedley and Carolyn Westhoff were among the 65 new IOM members announced Oct. 8, 2007, raising its total active IOM membership to 1,538.

Columbias new members were chosen through a highly selective process that recognizes individuals who have made significant contributions to advancing the medical science, health care, and public health fields, said Lee Goldman, M.D., executive vice president for health and biomedical sciences and dean of the faculties of health and medicine at Columbia University. We are proud to have them in our midst.

Kathryn Calame, Ph.D., is professor of microbiology and of biochemistry & molecular biophysics at Columbias College of Physicians and Surgeons. Dr. Calame studies gene regulation in the immune system, and her laboratory work focuses primarily on transcriptional regulation of lymphocyte development. A major focus of her current work is an unusual transcriptional repressor called Blimp-1 (B lymphocyte induced maturation protein). Her studies on Blimp-1 are revealing important aspects of regulation in both B and T cells.

Timothy A. Pedley, M.D., is the Henry and Lucy Moses Professor of Neurology, chairman of the Department of Neurology at P&S, and neurologist-in-chief at the Neurological Institute at New York-Presbyterian Hospital. Dr. Pedleys clinical and research interests are focused on epilepsy. His laboratory interests are in the role played by the ionic microenvironment in abnormal hippocampal and cortical excitability and in long-lasting changes in the hippocampus induced by repeated seizures.

Carolyn L. Westhoff, M.D., is professor of obstetrics and gynecology at P&S and professor of epidemiology and of population and family health at Columbias Mailman School of Public Health. She studies the effect of obesity on contraceptive effectiveness and leads several research projects investigating contraception and the epidemiology of womens reproductive health. Most recently, Dr. Westhoff was the principal investigator of a clinical trial of a novel oral contraceptive initiation method known as Quick Start.


Contact: Alex Lyda
Columbia University Medical Center

Related biology news :

1. Columbia research lifts major hurdle to gene therapy for cancer
2. Columbia study shows widely used artery clearing device does not help patients during heart attack
3. Columbia scientists develop cancer terminator viruses
4. Contaminants linked to sturgeon decline in Columbia river
5. Columbia University licenses next-generation DNA sequencing technology
6. New bird discovered on unexplored Columbian mountain
7. Columbia scientists determine 3-dimensional structure of cells fuel gauge
8. University of Manchester makes made-to-measure skin and bones a reality using inkjet printers
9. New protein discovered by Hebrew University researchers
10. Next Generation Body Scanner Launched By The University Of Manchester
11. Roundup®highly lethal to amphibians, finds University of Pittsburgh researcher
Post Your Comments:
(Date:11/16/2015)... Calif. , Nov 16, 2015  Synaptics ... of human interface solutions, today announced expansion of ... TouchView ™ touch controller and display driver ... revolution of smartphones. These new TDDI products add ... TD4100 (HD resolution), TD4302 (WQHD resolution), and TD4322 ...
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
(Date:11/10/2015)... , Nov. 10, 2015 ... behavioral biometrics that helps to identify and verify ... Signature is considered as the secure and accurate ... identification of a particular individual because each individual,s ... accurate results especially when dynamic signature of an ...
Breaking Biology News(10 mins):
(Date:11/26/2015)... , England , November 26, 2015 ... Lightpoint Medical, an innovative medical device company specializing in imaging ... grant from the European Commission as part of the Horizon ... the company to carry out a large-scale clinical trial in ... -->      (Logo: , --> ...
(Date:11/25/2015)... , November 25, 2015 2 ... première fois les différences entre les souches bactériennes ... celles des êtres humains . Ces recherches ... et envisager la prise en charge efficace de ... diagnostiqués chez les chats .    --> ...
(Date:11/25/2015)... 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... and CEO of Neurocrine Biosciences, will be presenting at ... New York . .   ... approximately 5 minutes prior to the presentation to download ... presentation will be available on the website approximately one ...
(Date:11/25/2015)... , Nov. 25, 2015 Orexigen® Therapeutics, Inc. ... participate in a fireside chat discussion at the Piper ... York . The discussion is scheduled for Wednesday, ... .  A replay will be available for ... Stilwell  , Julie NormartVP, Corporate Communications and Business ...
Breaking Biology Technology: